Turning Point Brands
Turning Point Brands' revenue rose 28.4% to $463 million in fiscal 2025. Its operating margin was 20.6%, down from 22.4% a year earlier. Free cash flow was $44 million, down 29.8%. It paid out $6 million in dividends and buybacks, 13% of free cash flow. The diluted share count fell 3.3%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Turning Point Brands does
Turning Point Brands makes, markets and distributes tobacco and alternative smoking products to adult consumers. It has two reportable segments. Zig-Zag sells rolling papers, tubes, finished cigars, make-your-own cigar wraps and other accessories, and it holds a majority stake in a Canadian marketing and distribution firm. Stoker's makes and sells moist snuff tobacco, markets modern oral nicotine products under the FRE and ALP names, and markets loose-leaf chewing tobacco.
The company says Zig-Zag is the number one rolling paper in the U.S. by market share, at approximately 33% according to a third-party data firm. It sells to about 900 distributors, who supply about 600 secondary wholesalers. At the end of 2025 its products were in approximately 220,000 retail locations in North America, including convenience stores and other traditional retailers, and it also sells online.
It makes its Stoker's snuff in Tennessee. It relies on suppliers for some products, including rolling papers sourced through a relationship with Republic Technology International and loose-leaf chewing tobacco made by Swedish Match. It sold off its former Creative Distribution Solutions segment on January 2, 2025, in exchange for a minority stake in the buyer. At the end of 2025 it had 484 full-time and part-time employees.
Its biggest risks, as it describes them
- Sales of tobacco products are generally expected to keep declining.
- Its reliance on a small number of outside suppliers and producers for its products.
- Strict and growing regulation, including the FDA's broad powers over tobacco and nicotine products.
- Competition from much larger tobacco companies, and from illicit or unauthorized products.
- The risk that licences to use certain brands and trademarks are ended or not renewed.
Income statement
From fiscal 2016 to 2025, earnings per share grew 8.5% a year and net income 9.0% a year, as new shares raised the share count by 4% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 128 | 106 | 118 | 49 | 223 |
| Debt incl. finance leases | 416 | 408 | 368 | 252 | 301 |
| Net debt (negative means net cash) | 288 | 302 | 250 | 203 | 78 |
| Net debt to EBITDA | 3.0x | 3.8x | 2.8x | — | — |
| Debt to equity | 3.1x | 3.7x | 2.4x | 1.3x | 0.8x |
| Interest coverage | 7.2x | 3.4x | 4.0x | 4.4x | 3.8x |
| Current ratio | 6.2x | 6.2x | 2.7x | 4.4x | 5.6x |
| Quick ratio | 4.0x | 3.3x | 1.8x | 2.3x | 4.1x |
Cash flow
Projections
Project Turning Point Brands' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 14, 2025 and November 13, 2026, no insider bought Turning Point Brands shares on the open market, and 7 insiders sold $6.0 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 12, 2026 | Brian WiggintonSr VP Finance & CAO | Sold | 4,000 | $91.67 | $366,680 | Form 4 |
| Mar 4, 2026 | Andrew FlynnChief Financial Officer | Sold | 2,000 | $97.57 | $195,140 | Form 4 |
| Dec 19, 2025 | David Edward GlazekExecutive Chairman, Director | Sold | 30,000 | $110.26 | $3.3 million | Form 4 |
| Dec 15, 2025 | H.C. Charles DiaoDirector | Sold | 2,000 | $108.20 | $216,400 | Form 4 |
| Nov 21, 2025 | Gregory H.A. BaxterDirector | Sold | 1,500 | $98.23 | $147,345 | Form 4 |
| Nov 20, 2025 | Stephen UsherDirector | Sold | 1,000 | $102.54 | $102,540 | Form 4 |
| Nov 19, 2025 | Brittani CushmanSr VP, General Counsel | Sold | 15,250 | $101.66 | $1.6 million | Form 4 |
| Nov 19, 2025 | Stephen UsherDirector | Sold | 1,000 | $101.00 | $101,000 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 7 of 9 | 8 of 9 | 8 of 9 |
| Rule of 40 | 20.0% | 28.3% | 37.9% |
| Altman Z'' | 3.93 | 4.77 | 5.63 |
| Accruals ratio | −5.0% | −5.1% | 0.1% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Fail |
| Debt fell relative to assets | Pass | Pass | Pass |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Fail | Pass | Pass |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | 7 of 9 | 8 of 9 | 8 of 9 |
Compare
Put Turning Point Brands side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Turning Point Brands | FY25 | 28.4% | 20.6% | 9.5% | 18.5% | — | 8 | |
| Universal | FY26 | −1.3% | 5.8% | 2.8% | 4.0% | 3.8x | 5 | Compare |
| Altria | FY25 | −3.1% | 42.5% | 39.0% | 39.2% | 2.1x | 7 | Compare |
| British American Tobacco | FY25 | −1.0% | 39.0% | 22.6% | 9.8% | — | 6 | Compare |
| Philip Morris International | FY25 | 7.3% | 36.6% | 26.2% | 35.4% | 2.6x | 7 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 206 | 286 | 333 | 362 | 405 | 446 | 321 | 325 | 361 | 463 |
| Revenue growth | 4.5% | 38.6% | 16.4% | 8.8% | 11.9% | 10.0% | −27.9% | 1.2% | 10.9% | 28.4% |
| Gross profit | 100 | 125 | 143 | 137 | 190 | 218 | 178 | 183 | 202 | 264 |
| Research and development | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating income | 44 | 50 | 48 | 27 | 64 | 90 | 74 | 83 | 81 | 95 |
| Net income | 27 | 20 | 25 | 16 | 38 | 52 | 12 | 38 | 40 | 58 |
| Diluted EPS (US$) | 1.49 | 1.04 | 1.28 | 0.78 | 1.85 | 2.52 | 0.64 | 2.01 | 2.14 | 3.11 |
| Diluted shares (millions) | 18 | 20 | 20 | 23 | 23 | 22 | 18 | 20 | 19 | 19 |
| Cash flow | ||||||||||
| Cash from operations | 9 | 30 | 13 | 38 | 44 | 68 | 30 | 67 | 67 | 57 |
| Capital expenditure | 3 | 2 | 2 | 5 | 6 | 6 | 8 | 6 | 5 | 14 |
| Free cash flow | 6 | 28 | 11 | 33 | 38 | 62 | 22 | 61 | 62 | 44 |
| Dividends paid | 0 | 1 | 2 | 4 | 4 | 4 | 4 | 4 | 5 | 6 |
| Share buybacks | 0 | 0 | 0 | 0 | 10 | 39 | 29 | 0 | 5 | 0 |
| Acquisitions | 24 | 0 | 19 | 8 | 39 | 16 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 0 | 1 | 1 | 4 | 3 | 8 | 5 | 7 | 7 | 7 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 3 | 3 | 3 | 95 | 42 | 128 | 106 | 118 | 49 | 223 |
| Debt incl. finance leases | 203 | 194 | 195 | — | 302 | 416 | 408 | 368 | 252 | 301 |
| Total assets | 285 | 282 | 339 | 447 | 496 | 602 | 572 | 569 | 493 | 764 |
| Total liabilities | 251 | 229 | 257 | 340 | 379 | 468 | 459 | 417 | 303 | 392 |
| Shareholders' equity | 34 | 53 | 83 | 107 | 118 | 134 | 112 | 151 | 190 | 372 |
| Margins and ratios | ||||||||||
| Gross margin | 48.8% | 43.7% | 42.9% | 37.9% | 46.9% | 48.9% | 55.4% | 56.3% | 55.9% | 57.1% |
| Operating margin | 21.3% | 17.4% | 14.6% | 7.5% | 15.9% | 20.3% | 23.0% | 25.5% | 22.4% | 20.6% |
| Net margin | 13.1% | 7.1% | 7.6% | 4.5% | 9.4% | 11.7% | 3.6% | 11.8% | 11.0% | 12.6% |
| Free cash flow margin | 2.9% | 9.7% | 3.2% | 9.1% | 9.3% | 13.9% | 7.0% | 18.8% | 17.3% | 9.5% |
| Rule of 40 (growth + FCF margin) | 7.4% | 48.3% | 19.7% | 17.9% | 21.2% | 23.9% | −20.9% | 20.0% | 28.3% | 37.9% |
| Return on capital | 19.9% | 15.1% | 14.9% | — | — | 17.7% | 13.1% | 12.5% | 15.0% | 18.5% |
| Return on equity | — | 46.2% | 37.2% | 17.2% | 34.1% | 41.5% | 9.5% | 29.3% | 23.3% | 20.7% |
| Return on assets | 10.2% | 7.1% | 8.1% | 4.1% | 8.1% | 9.5% | 2.0% | 6.7% | 7.5% | 9.2% |
| Net debt to EBITDA | 4.4x | 3.7x | 3.7x | — | 3.8x | 3.0x | 3.8x | 2.8x | — | — |